MedTech Valuation Multiples
Explore private market MedTech valuation multiples with benchmarks structured by stage and region. Updated quarterly.
MedTech
Medical Technology companies design and manufacture devices, diagnostics, and therapeutic systems that improve clinical care. Private market valuations reflect regulatory approval status, clinical adoption, reimbursement coverage, and the strength of IP protection in a capital-intensive development environment.
The category spans surgical robotics, imaging systems, point-of-care diagnostics, implantable devices, and digital surgery platforms. DealMatrix tracks valuation dynamics across 7 funding stages and all major global regions, updated every quarter.
Sector
MedTech
Health & Life Sciences
Sector tracked since
2002
23+ years of data
EV/SALES & EV/EBITDA ACROSS
6 Regions · 7 Stages
Modelled independently via proprietary econometric approach
UPDATE FREQUENCY
Quarterly
Data updates & model improvement
MedTech Valuation Multiples
Select a region and funding stage to preview how MedTech companies are valued in private markets. Full data available on the platform.
The Venionaire DealMatrix Multiples Model
DealMatrix multiples are derived through a five-step model combining public capital market comparables, proprietary VC/PE/M&A transaction data, and macroeconomic indicators.
The model produces three components: The reported public multiple, the model-predicted multiple, and the lower bound predicted multiple averaged into the DealMatrix Composite, then adjusted for region and funding stage. The methodology follows the IPEV Guidelines 2025.
Brainomix Completes £14M ($18M) Series C Round to Advance Its Transformative AI Imaging Technology in Healthcare
raised
Valuation
Audio health startup secures £12.4m from YFM
raised
Valuation
Region
Stage
“Size of a grain of rice”: Robeauté raises €27.2 million to transform neurosurgery with microrobots
raised
Valuation
CorFlow Therapeutics AG Completes €44 Million Series B Financing
raised
Valuation
Eurazeo Backs Moria’s Global Expansion Plans
raised
Valuation
Region
Stage
TRiCares Raises $50m in Series D Financing to Support Upcoming Clinical Milestones
raised
Valuation
Health & Life Sciences
BioTech
